PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

Placebo Capsules to Match Emtricitabine Capsules, 200mg.

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 10, 2026 · PHASE 1 TRIAL

Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study

ClinicalTrials.gov

Phase 1 safety trial in a special population (MCI patients) with no results yet reported; designed to evaluate tolerability and collect preliminary cognitive and biomarker data over 12 weeks.

PreliminaryAlzheimer Dementia (AD)Emtricitabine (FTC)Placebo to Match Emtricitabine 200mg/Tenofovir Alafenamide 25 mg.

Reported

Planned enrollment48

Study duration (treatment phase)12 weeks

Primary outcome measureNumber of participants with treatment-relat…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support